Insmed (NASDAQ:INSM) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says
Insmed (NASDAQ:INSM – Get Free Report) had its target price hoisted by equities research analysts at Stifel Nicolaus from $88.00 to $97.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. Stifel Nicolaus’ price target would suggest a potential upside of 21.86% […]
Insmed (NASDAQ:INSM – Get Free Report) had its target price hoisted by equities research analysts at Stifel Nicolaus from $88.00 to $97.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. Stifel Nicolaus’ price target would suggest a potential upside of 21.86% […]
